fbpx
Lesson 6 of 8
In Progress

RATE AND RYTHM CONTROL STRATEGY

RATE CONTROL STRATEGY

  • Most commonly used are beta-blockers which are more effective at rest
  • Also, nondihydropyridine calcium channel blockers (diltiazem and verapamil) which are effective both at rest and during exercise.
  • Digoxin is also used for sedentary patients and those with reduced left ventricular function.
  • Amiodarone can also be used, although rarely, if other agents have failed, are contraindicated, or for critically ill patients.
  • maintain a ventricular rate that protects the patient from the consequences of tachycardia.
  • Obtained by AV nodal conduction slowing drugs which aims to reach the initial target ventricular rate of <100 bpm (lenient rate) at rest.
  • If complaints persist despite lenient rate achievement, strict control should be done in which < 80 bpm at rest and < 110 bpm during moderate exercise


RHYTHM CONTROL STRATEGY

  • targets sinus rhythm restoration by pharmacological cardioversion (CV) antiarrhythmic drugs ± electrocardioversion and maintenance with antiarrhythmic drugs.
  • This is recommended for patients with paroxysmal or persistent AF in the presence of favorable clinical and echocardiographic parameters

1.ELECTRICAL CARDIOVERSION

  • involves delivery of an electric shock synchronized with intrinsic activity of the heart
  • performed with the patient in a fasting state and with adequate sedation for elective cases.
  • success of electrical CV depends on adequacy of delivered current flow and determinants such as nature of shock waveform and level of delivered energy
  • Initial requirement is ≥200 joules for monophasic and ≥100 joules for biphasic waveform
  • RISKS AND COMPLICATIONS 
    • Thromboembolic events
    • Post-cardioversion arrhythmias
    • Risks of general anesthesia
    • Skin burns – common
    • Hypoxia or hypoventilation
    • Hypotension – rare
    • Pulmonary edema – rare

2.PHARMACOLOGICAL CARDIOVERSION

  • considered as management for hemodynamically stable patients
  • requires continuous medical supervision and ECG monitoring during drug administration and for a period afterwards until drug elimination half-life